Substituted nucleosides, nucleotides and analogs thereof
US10052342B2 · kind B2 · utility
18Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2017 |
| Grant date | Aug 21, 2018 |
| Priority date | — |
| Expiry date | Feb 8, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7064
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are nucleosides, nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a Filoviridae virus infection with one or more nucleosides and/or nucleotide analogs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.